Elekta AB (publ) (EKTAF)
USD 5.0
(0.0%)
USD 5.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 4.76 Billion SEK | 36.86% |
| 2023 | 3.46 Billion SEK | 16.88% |
| 2022 | 2.96 Billion SEK | 13.62% |
| 2021 | 2.6 Billion SEK | -13.24% |
| 2020 | 3 Billion SEK | -0.69% |
| 2019 | 3.02 Billion SEK | 15.1% |
| 2018 | 2.62 Billion SEK | 5.33% |
| 2017 | 2.49 Billion SEK | -12.76% |
| 2016 | 2.86 Billion SEK | -14.21% |
| 2015 | 3.33 Billion SEK | 17.43% |
| 2014 | 2.84 Billion SEK | 3.65% |
| 2013 | 2.74 Billion SEK | 12.2% |
| 2012 | 2.44 Billion SEK | 8.15% |
| 2011 | 2.25 Billion SEK | 2.03% |
| 2010 | 2.21 Billion SEK | 7.43% |
| 2009 | 2.06 Billion SEK | 34.46% |
| 2008 | 1.53 Billion SEK | 8.35% |
| 2007 | 1.41 Billion SEK | 5.21% |
| 2006 | 1.34 Billion SEK | 21.63% |
| 2005 | 1.1 Billion SEK | 31.86% |
| 2004 | 838 Million SEK | 16.07% |
| 2003 | 722 Million SEK | -15.06% |
| 2002 | 850 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 1.13 Billion SEK | 10.23% |
| 2024 Q1 | 1.12 Billion SEK | 8.84% |
| 2024 FY | 3.39 Billion SEK | -2.08% |
| 2024 Q2 | 1.07 Billion SEK | -4.02% |
| 2024 Q3 | 1.02 Billion SEK | -4.56% |
| 2023 Q2 | 1.12 Billion SEK | 2.47% |
| 2023 Q3 | 1.17 Billion SEK | 4.46% |
| 2023 Q4 | 1.02 Billion SEK | -12.2% |
| 2023 FY | 3.46 Billion SEK | 16.88% |
| 2023 Q1 | 1.09 Billion SEK | 7.35% |
| 2022 Q3 | 984 Million SEK | 7.66% |
| 2022 Q4 | 1.02 Billion SEK | 3.66% |
| 2022 FY | 2.96 Billion SEK | 13.62% |
| 2022 Q1 | 981 Million SEK | 3.26% |
| 2022 Q2 | 914 Million SEK | -6.83% |
| 2021 FY | 2.6 Billion SEK | -13.24% |
| 2021 Q4 | 950 Million SEK | 2.04% |
| 2021 Q1 | 977 Million SEK | 1.03% |
| 2021 Q2 | 930 Million SEK | -4.81% |
| 2021 Q3 | 931 Million SEK | 0.11% |
| 2020 Q2 | 1.08 Billion SEK | 0.56% |
| 2020 Q3 | 1.05 Billion SEK | -2.59% |
| 2020 Q4 | 967 Million SEK | -8.34% |
| 2020 FY | 3 Billion SEK | -0.69% |
| 2020 Q1 | 1.07 Billion SEK | 1.22% |
| 2019 Q4 | 1.06 Billion SEK | 9.02% |
| 2019 Q3 | 976 Million SEK | 0.0% |
| 2019 Q1 | 889 Million SEK | 13.54% |
| 2019 Q2 | 976 Million SEK | 9.79% |
| 2019 FY | 3.02 Billion SEK | 15.1% |
| 2018 Q2 | 814 Million SEK | -6.33% |
| 2018 Q4 | 783 Million SEK | -0.25% |
| 2018 FY | 2.62 Billion SEK | 5.33% |
| 2018 Q1 | 869 Million SEK | 4.83% |
| 2018 Q3 | 785 Million SEK | -3.56% |
| 2017 Q3 | 774 Million SEK | 0.91% |
| 2017 FY | 2.49 Billion SEK | -12.76% |
| 2017 Q1 | 742 Million SEK | -11.03% |
| 2017 Q4 | 829 Million SEK | 7.11% |
| 2017 Q2 | 767 Million SEK | 3.37% |
| 2016 FY | 2.86 Billion SEK | -14.21% |
| 2016 Q4 | 834 Million SEK | -1.77% |
| 2016 Q1 | 887 Million SEK | -13.46% |
| 2016 Q3 | 849 Million SEK | -0.93% |
| 2016 Q2 | 857 Million SEK | -3.38% |
| 2015 FY | 3.33 Billion SEK | 17.43% |
| 2015 Q3 | 779 Million SEK | 1.43% |
| 2015 Q4 | 1.02 Billion SEK | 31.58% |
| 2015 Q1 | 763 Million SEK | 10.42% |
| 2015 Q2 | 768 Million SEK | 0.66% |
| 2014 Q1 | 708 Million SEK | 14.19% |
| 2014 FY | 2.84 Billion SEK | 3.65% |
| 2014 Q4 | 691 Million SEK | -2.26% |
| 2014 Q2 | 734 Million SEK | 3.67% |
| 2014 Q3 | 707 Million SEK | -3.68% |
| 2013 Q3 | 709 Million SEK | -1.25% |
| 2013 Q2 | 718 Million SEK | 3.61% |
| 2013 FY | 2.74 Billion SEK | 12.2% |
| 2013 Q1 | 693 Million SEK | 5.8% |
| 2013 Q4 | 620 Million SEK | -12.55% |
| 2012 Q4 | 655 Million SEK | 1.24% |
| 2012 Q1 | 535 Million SEK | -6.47% |
| 2012 FY | 2.44 Billion SEK | 8.15% |
| 2012 Q2 | 605 Million SEK | 13.08% |
| 2012 Q3 | 647 Million SEK | 6.94% |
| 2011 Q2 | 563 Million SEK | -1.57% |
| 2011 Q4 | 572 Million SEK | 5.15% |
| 2011 Q3 | 544 Million SEK | -3.37% |
| 2011 Q1 | 572 Million SEK | -5.14% |
| 2011 FY | 2.25 Billion SEK | 2.03% |
| 2010 Q1 | 553 Million SEK | 0.0% |
| 2010 Q3 | 542 Million SEK | 5.24% |
| 2010 Q4 | 603 Million SEK | 11.25% |
| 2010 Q2 | 515 Million SEK | -6.87% |
| 2010 FY | 2.21 Billion SEK | 7.43% |
| 2009 FY | 2.06 Billion SEK | 34.46% |
| 2008 FY | 1.53 Billion SEK | 8.35% |
| 2007 FY | 1.41 Billion SEK | 5.21% |
| 2006 FY | 1.34 Billion SEK | 21.63% |
| 2005 FY | 1.1 Billion SEK | 31.86% |
| 2004 FY | 838 Million SEK | 16.07% |
| 2003 FY | 722 Million SEK | -15.06% |
| 2002 FY | 850 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -166279.879% |
| Ansell Limited | 495.5 Million USD | -861.453% |
| Ansell Limited | 495.5 Million USD | -861.453% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -5653.36% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -275155.438% |
| Psykey, Inc. | 1.21 Million USD | -392489.907% |
| ConvaTec Group Plc | 910.31 Million USD | -423.335% |
| ConvaTec Group Plc | 872.5 Million USD | -446.017% |
| Encision Inc. | 3.77 Million USD | -126040.367% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -3359300.893% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -4333527.457% |
| Innovative MedTech Inc. | 6.09 Million USD | -78011.153% |
| LifePoint, Inc. | 7.42 Million USD | -64071.382% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -74935.439% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -557092.982% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -655977.253% |
| Reflect Scientific, Inc. | 1.06 Million USD | -447771.061% |
| SmileDirectClub, Inc. | 517 Million USD | -821.465% |
| Sector 10, Inc. | 39.84 Thousand USD | -11956530.86% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 28.286% |
| SheerVision, Inc. | 2.33 Million USD | -204220.144% |
| United Health Products, Inc. | 2.42 Million USD | -196229.01% |
| Vasamed, Inc. | 4.67 Million USD | -101849.233% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -185862.704% |
| Yubo International Biotech Limited | 1.25 Million USD | -378633.976% |